189 results on '"Xi, Jianying"'
Search Results
2. Peripheral immune landscape for hypercytokinemia in myasthenic crisis utilizing single-cell transcriptomics
3. Diagnosis of Challenging Spinal Muscular Atrophy Cases with Long-Read Sequencing
4. Clinical outcome and peripheral immune profile of myasthenic crisis with omicron infections: A prospective cohort study
5. Clinical features and genetic spectrum of a multicenter Chinese cohort with myotonic dystrophy type 1
6. Myasthenic crisis in thymoma-associated myasthenia gravis: a multicenter retrospective cohort study
7. Subclinical cardiac involvement present as electrocardiographic abnormalities in various neuromuscular diseases
8. Increased serum IL-2, IL-4, IL-5 and IL-12p70 levels in AChR subtype generalized myasthenia gravis
9. Plasma exchange versus intravenous immunoglobulin in AChR subtype myasthenic crisis: A prospective cohort study
10. Pneumonia and systemic inflammatory response syndrome as predictors for difficult-/prolonged-weaning after invasive ventilation in myasthenic crisis: A retrospective analysis of a Chinese cohort
11. Pseudoexon activation by deep intronic variation in GNE myopathy with thrombocytopenia.
12. A ROS storm generating nanocomposite for enhanced chemodynamic therapy through H2O2 self-supply, GSH depletion and calcium overload.
13. A predictive nomogram for short‐term outcomes of myasthenia gravis patients treated with low‐dose rituximab.
14. Comparison of anti-acetylcholine receptor profiles between Chinese cases of adult- and juvenile-onset myasthenia gravis using cell-based assays
15. The correlation of clinical evaluation with life quality and mental status in a Chinese cohort with dysferlinopathy
16. Independent risk factors for in-hospital outcome of myasthenic crisis: a prospective cohort study.
17. Nomogram for short-term outcome assessment in AChR subtype generalized myasthenia gravis
18. Congenital myasthenia syndrome in a Chinese family with mutations in MUSK: A hotspot mutation and literature review
19. Clinical characteristics and long term follow-up of Lambert-Eaton myasthenia syndrome in patients with and without small cell lung cancer
20. Effectiveness and safety of tacrolimus therapy for myasthenia gravis: A single arm meta-analysis
21. HLA typing using next-generation sequencing for Chinese juvenile- and adult-onset myasthenia gravis patients
22. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China
23. Diagnostic delay in late‐onset Pompe disease among Chinese patients: A retrospective study.
24. GNE myopathy in Chinese population: hotspot and novel mutations
25. Responsiveness to low-dose rituximab in refractory generalized myasthenia gravis
26. Novel mutations in the C-terminal region of GMPPB causing limb-girdle muscular dystrophy overlapping with congenital myasthenic syndrome
27. Electromyographic Features in a Chinese Cohort With Hereditary Skeletal Muscle Channelopathies
28. Loss-of-function mutations in Lysyl-tRNA synthetase cause various leukoencephalopathy phenotypes
29. Efficacy and safety of tacrolimus for myasthenia gravis: a systematic review and meta-analysis
30. Identification of gene mutations in patients with primary periodic paralysis using targeted next-generation sequencing
31. NOTCH2NLC‐related oculopharyngodistal myopathy type 3 with cardiomyopathy and nephropathy.
32. Causal relationships between mood instability and autoimmune diseases: A mendelian randomization analysis
33. A Randomized Control Study on the Efficacy of Thymectomy in Patients with Nonthymomatous (without Chest Tumor) Myasthenia Gravis
34. Short-term outcome prediction for myasthenia gravis: an explainable machine learning model.
35. Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies
36. Correction: GNE myopathy in Chinese population: hotspot and novel mutations
37. Clinical features and ETFDH mutation spectrum in a cohort of 90 Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency
38. Intrafamilial phenotypic heterogeneity in GIPC1-related oculopharyngodistal myopathy type 2: a case report
39. Increased Frequency of Myeloid-Derived Suppressor Cells in Myasthenia Gravis After Immunotherapy.
40. Clinical Features of Myasthenia Gravis With Antibodies to MuSK Based on Age at Onset: A Multicenter Retrospective Study in China.
41. A Targeted Complement Inhibitor CRIg/FH Protects Against Experimental Autoimmune Myasthenia Gravis in Rats via Immune Modulation.
42. Molecular landscape of DYSF mutations in dysferlinopathy: From a Chinese multicenter analysis to a worldwide perspective.
43. Comorbid Autoimmune Diseases in Patients With Myasthenia Gravis: A Retrospective Cross-Sectional Study of a Chinese Cohort.
44. Human-induced pluripotent stem cell line (FDHSi001-A) derived from a patient with a CGG repeat expansion in the 5′UTR of GIPC1
45. Short-term effect of low-dose rituximab on myasthenia gravis with muscle-specific tyrosine kinase antibody.
46. Palpebral portion of the orbicularis oculi muscle to repetitive nerve stimulation testing: A potential assessment indicator in patients with generalized myasthenia gravis
47. Clinical heterogeneity and a high proportion of novel mutations in a Chinese cohort of patients with dysferlinopathy
48. In‐depth peripheral CD4+ T profile correlates with myasthenic crisis.
49. 5' UTR CGG repeat expansion in GIPC1 is associated with oculopharyngodistal myopathy.
50. Isaacs syndrome with CASPR2 antibody: A series of three cases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.